Effects of mood state and psychosocial functioning on plasma interleukin-6 in adult patients before cardiac surgery

International Journal of Psychiatry in Medicine

Volumn 35, Issue 4, 2005, Pages 363-376

  Ai, Amy L ^a,b   Kronfol, Ziad ^b   Seymour, Elisabeth ^b   Bolling, Steve F ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Anxiety; BMI; Cardiac surgery; Depression; Interleukin 6; Psychoneuroimmunology; Psychosocial functioning

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ANXIETY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY MASS; CHRONIC DISEASE; CORRELATION ANALYSIS; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HEART SURGERY; HUMAN; INSTRUMENT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD; MULTIVARIATE ANALYSIS; OUTPATIENT DEPARTMENT; PAIN; PHYSICAL EXAMINATION; PREOPERATIVE CARE; SOCIAL PSYCHOLOGY; UNIVERSITY HOSPITAL;

ADULT; AFFECT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; CORONARY ARTERY BYPASS; DEPRESSION; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PREOPERATIVE CARE; SEVERITY OF ILLNESS INDEX;

EID: 33644556154     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/2ELG-RDUN-X6TU-FGC8     Document Type: Article

References (46)

1. Wuslin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic review. Psychosomatic Medicine 2003;65:201-210.
2. Thomas AJ, Kalaria RN, OBrien JT. Depression and vascular disease: What is the relationship? Journal of Affective Disorders 2004;79:81-95.
3. Frasure-Smith N, Lesperance F, Juneau M, Talajic M, Bourassa MG. Gender, depression, and one-year prognosis after myocardial infarction. Psychosomatic Medicine 1999;61:26-37.
4. Lane D, Carroll D, Lip GH. Anxiety, depression, and prognosis after myocardial infarction: Is there a causal association? Journal of the American College of Cardiology 2003;42:1808-1810.
5. Strik J, Denollet J, Lousberg R, et al. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. Journal of the American College of Cardiology 2003;42:1801-1807.
6. Perski A, Feleke E, Anderson G, et al. Emotional distress before coronary bypass grafting limits the benefits of surgery. American Heart Journal 1998;136:510-517.
7. Saur CD, Granger BB, Muhlbaier LH, et al. Depressive symptoms and outcome of coronary artery bypass grafting. American Journal of Critical Care 2001;10:4-10.
8. Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP. Relation between depression after coronary artery bypass surgery and 12-month outcome: A prospective study. Lancet. 2001;358:1766-1771.
9. Pignay-Demaria V, Lesperance F, Demaria RG, Frasure-Smith N, Perrault LP. Depression and anxiety and outcomes of coronary artery bypass surgery. Annals of Thoracic Surgery 2003;75:314-321.
10. Pasic J, Levy WC, Sullivan MD. Cytokines in depression and heart failure. Psychosomatic Medicine 2003;65:181-193.
11. Kronfol Z. Depression and immune dysregulation: A critical review of existing evidence. International Journal of Neuropsychopharmacology 2002;5:333-343.
12. Kiecolt-Glaser JK, Page GG, MacCallum RC, Atkinson C, Malarkey WB, Glaser R: Chronic stress and age-related increases in the proimflammatory cytokine IL-6. Proceedings of the National Academy of Sciences 2003;100(15):9090-9095.
13. Boeken U, Feindt P, Zimmermann N, Kalweit G, Petzold T, Gams E. Increased preoperative C-reactive protein (CRP)-values without signs of an infection and complicated course after cardiopulmonary bypass (CPB)-operations. European Journal of Cardiothoracic Surgery 1998;13(5):541-545.
14. Fransen EJ, Maessen JG, Elenbaas TW, van Aarnhem EE, van Dieijen-Visser MP. Enhanced preoperative C-reactive protein plasma levels as a risk factor for postoperative infections after cardiac surgery. Annals of Thoracic Surgery 1999;67(1):134-138.
15. Gaudino M, Nasso G, Andreotti F, et al. Preoperative C-reactive protein level and outcome following coronary surgery. European Journal of Cardiothoracic Surgery 2002;22(4):521-526.
16. Goebel MU, Mills PJ, Irwin MR, Zeigler MG. Interleukin-6 and tumor necrosis factor-a production after acute psychological stress, exercise, and infused isoproterenol: Differential effects and pathways. Psychosomatic Medicine 2000;62:591-598.
17. Maes M, Meltzer H, Bosmans E. Increased plasma levels of interleukin-6, soluble interleukin-2 and transferrin receptors in major depression. Journal of Affective Disorders 1995;34:301-309.
18. Pollmacher T, Schuld A, Hinze-Selch D. Cytokines and schizophrenia. In: Kronfol Z (ed.), Cytokines and mental health. Boston: Kluwer; 2003:339-368.
19. Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong S, Lubaroff DM. Life stress and elevated IL-6 in healthy elderly women. Journal of Gerontology and Biological Scientific and Medical Science 1999;54:M434-M439.
20. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychiatric Measures 1977;1:385-401.
21. Spielberger CD. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto: Consulting Psychologists Press; 1983.
22. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health and Economics 1993;2:217-227.
23. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997;9:853-858.
24. Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong S, Lubaroff DM. Life stress and elevated IL-6 in healthy elderly women. Journal of Gerontology and Biological and Scientific Medical Science 1999;54:M434-M439.
25. Maes M, Song C, Lin A, et al. The effects of psychological stress on humans: Increased production of pro-inflammatory cytokines and th1-like response in stress-induced anxiety. Cytokine 1998;10:313-318.
26. Segerstrom SC, Miller GE. Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychology Bulletin 2004;130:601-630.
27. Burker EJ, Blumenthal JA, Feldman M, et al. Depression in male and female patients undergoing cardiac surgery. British Journal of Clinical Psychology 1995;34(Pt 1):119-128.
28. Andrew MJ, Baker RA, Kneebone AC, Knight JL. Mood state as a predictor of neuropsychological deficits following cardiac surgery. Journal of Psychosomatic Research 2000;48(6):537-546.
29. Vingerhoets G. Perioperative anxiety and depression in open-heart surgery. Psychosomatics 1998;39:30-37.
30. Kiechl S, Egger G, Mayr M, et al. Chronic infections and the risk of carotid atherosclerosis: Prospective results from a large population study. Circulation 2001;103(8):1064-1070.
31. De Jongh RF, Vissers KC, Meert TF, Booij LHDJ, De Deyne CS, Heylen RJ. The role of nocoception and pain. Anesthesia and Analgesia 2003; 96:1096-1103.
32. Mulligan ED, Twining C, Chacur M, et al. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. Journal of Neuroscience 2003;23(3):1026-1040.
33. Arruda JL, Sweitzer S, Rutkowski MD, DeLeo JA. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: Possible immune modulation in neuropathic pain. Brain Research 2000;879(1/2):216-225.
34. Ramos EJ, Xu Y, Romanova I, et al. Is obesity an inflammatory disease? Surgery 2003;134(2):329-335.
35. Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behavior and Immunology 2003;17(4):276-285.
36. Berthier MT, Paradis AM, Tchernof A, et al. The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. Journal of Human Genetics 2003;48(1):14-19.
37. Stenlof K, Wernstedt I, Fjallman T, Wallenius V, Wallenius K, Jansson JO. Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. Journal of Clinical Endocrinology and Metabolism 2003;88(9):4379-4383.
38. Wallenius K, Wallenius V, Sunter D, Dickson SL, Jannson JO. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochemical and Biophysical Research Community 2002;2931:560-565.
39. Wallenius V, Wallenius K, Ahren B, et al. Interleukin-6-deficient mice develop mature-onset obesity. Natural Medicine 2002;8:75-79.
40. Potapov EV, Loebe M, Anker S, et al. Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. European Heart Journal 2003;24:1933-1941.
41. Ai AL, Bolling SF. The use of complementary and alternative therapies of middle-aged and older cardiac patients. American Journal of Medical Qualification 2002;17(1):21-27.
42. Sharma R, Anker SD. Cytokines, apoptosis and cachexia: The potential for TNF antagonism. International Journal of Cardiology 2002;85:161-171.
43. MacGowan GA, Mann DL, Kormos RL, Feldman AM, Murali S. Circulating Interleukin-6 in severe heart failure. American Journal of Cardiology 1997;79:1128-1131.
44. Davos CH, Doehner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: The importance of obesity. Journal of Cardiac Failure 2003;9(1):29-35.
45. Colantoni A, Idilman R, De Maria N, et al. Hepatic apoptosis and proliferation in male and female rats fed alcohol: Role of cytokines. Alcohol Clinical and Experimental Research 2003;27(7):1184-1189.
46. Laso FJ, Lapena P, Madruga JI, et al. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: Relationship with liver disease and ethanol intake. Alcohol Clinical and Experimental Research 1997;21(7):1226-1231.